Contents
Current Pharmaceutical Design, Volume 15 - Number 16
Editorial [Hot Topic: Inflammation as Target for Pharmaceutical Intervention in Cancer (Executive Editors: R.M. Schiffelers and K.E. de Visser)]
, 15(16): 1822 - 1824Raymond M. Schiffelers and Karin E. de Visser
DOI: 10.2174/138161209788453257
Targeted Delivery of Anti-Inflammatory Agents to Tumors
, 15(16): 1825 - 1843Maria Coimbra, Sylvia A. Kuijpers, Sebastiaan P. van Seters, Gert Storm and Raymond M. Schiffelers
DOI: 10.2174/138161209788453220
Towards Understanding the Role of Cancer-Associated Inflammation in Chemoresistance
, 15(16): 1844 - 1853Karin E. de Visser and Jos Jonkers
DOI: 10.2174/138161209788453239
III. Angiogenesis: Complexity of Tumor Vasculature and Microenvironment
, 15(16): 1854 - 1867Mitsuko Furuya, Yoshikazu Yonemitsu and Ichiro Aoki
DOI: 10.2174/138161209788453275
Mast Cells as Target in Cancer Therapy
, 15(16): 1868 - 1878Tom Groot Kormelink, Abulikemu Abudukelimu and Frank A. Redegeld
DOI: 10.2174/138161209788453284
Regulatory T Cells: Major Players in the Tumor Microenvironment
, 15(16): 1879 - 1892Marc Beyer and Joachim L. Schultze
DOI: 10.2174/138161209788453211
Designed Multiple Ligands: An Emerging Anti-HIV Drug Discovery Paradigm
, 15(16): 1893 - 1917Peng Zhan and Xinyong Liu
DOI: 10.2174/138161209788453266
Scientific and Clinical Challenges in Sepsis
, 15(16): 1918 - 1935Luis Ulloa, Michael Brunner, Laura Ramos and Edwin A. Deitch
DOI: 10.2174/138161209788453248
Webmaster Contact: info@benthamscience.org